AIHTA - Publications - Search - [High-dose lymphoablative therapy (HDLT) for severe autoimmune diseases]

Wild, C. (2003): [High-dose lymphoablative therapy (HDLT) for severe autoimmune diseases]. HTA-Newsletter 21: pp. 2-3.

[thumbnail of HTA-Newsletter 21]
PDF (HTA-Newsletter 21) - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader

Official URL:

Item Type:HTA Newsletter Item
Keywords:High dose ymphoablative therapy (HDLT), severe autoimmune diseases, immune system, autologous stem cell transplantation, cyclophosphamide
Subjects:WD Disorders of systemic, metabolic or environmental origin > WD 300-375 Immunologic and collagen diseases
QV Pharmacology, toxicology, pharmacy > QV 247-269 Anti-inflammatory agents. Anti-infective agents
WO Surgery > WO 660-690 Transplantation
Related URLs:
Deposited on:04 Jan 2008 18:57
Last Modified:15 Jul 2020 17:24

Repository Staff Only: item control page